These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 22230447)

  • 1. Chemotherapy with cytotoxic and cytostatic agents in brain cancer.
    Blakeley J; Grossman SA
    Handb Clin Neurol; 2012; 104():229-54. PubMed ID: 22230447
    [No Abstract]   [Full Text] [Related]  

  • 2. Novel dual-reporter preclinical screen for antiastrocytoma agents identifies cytostatic and cytotoxic compounds.
    Hawes JJ; Nerva JD; Reilly KM
    J Biomol Screen; 2008 Sep; 13(8):795-803. PubMed ID: 18664715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular profile of the BCL2 family of the apoptosis related genes in breast cancer cells after treatment with cytotoxic/cytostatic drugs.
    Thomadaki H; Scorilas A
    Connect Tissue Res; 2008; 49(3):261-4. PubMed ID: 18661356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytotoxic chemotherapeutic management of newly diagnosed glioblastoma multiforme.
    Fadul CE; Wen PY; Kim L; Olson JJ
    J Neurooncol; 2008 Sep; 89(3):339-57. PubMed ID: 18712284
    [No Abstract]   [Full Text] [Related]  

  • 5. Novel anti-brain tumor cytotoxins specific for cancer cells.
    Debinski W; Gibo DM; Obiri NI; Kealiher A; Puri RK
    Nat Biotechnol; 1998 May; 16(5):449-53. PubMed ID: 9592393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pharmacoeconomic aspects of oral cytostatic agents].
    Poquet Jornet JE; Carrera-Hueso FJ; Gasent Blesa JM; Peris Godoy M
    Farm Hosp; 2011 May; 35 Suppl 2():25-31. PubMed ID: 22445506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Update in the management of extravasations of cytocytostatic agent].
    Conde-Estévez D; Mateu-de Antonio J
    Farm Hosp; 2012; 36(1):34-42. PubMed ID: 21798785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytotoxic chemotherapy: new players, new tactics.
    Vail DM; Thamm DH
    J Am Anim Hosp Assoc; 2005; 41(4):209-14. PubMed ID: 15995156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cytostatic and cytotoxic waste - rules of conduct in Poland].
    Furtak-Niczyporuk M; Jaroszyński J; Mela A; Staniszewska A; Piotrowska J; Zimmermann A; Czajka-Bełz A; Dreher P; Dąbrowski J; Kapka-Skrzypczak L
    Med Pr; 2019 Jun; 70(3):377-391. PubMed ID: 31110397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemotherapy for brain tumors with polymer drug delivery.
    Attenello F; Raza SM; Dimeco F; Olivi A
    Handb Clin Neurol; 2012; 104():339-53. PubMed ID: 22230452
    [No Abstract]   [Full Text] [Related]  

  • 11. [Chemotherapy for brain tumor].
    Takahashi H; Tanaka R
    Nihon Rinsho; 2005 Sep; 63 Suppl 9():452-5. PubMed ID: 16201563
    [No Abstract]   [Full Text] [Related]  

  • 12. Pemetrexed: new indication. Untreated non-small cell lung cancer: just another cytotoxic drug. No better than the gemcitabine-cisplatin combination with a different safety profile, as is the case for other cytotoxic drugs.
    Prescrire Int; 2009 Jun; 18(101):114. PubMed ID: 19637425
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical trial designs for multiple myeloma.
    Hoering A; Crowley J
    Clin Adv Hematol Oncol; 2007 Apr; 5(4):309-16. PubMed ID: 17607290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug delivery to brain tumours: challenges and progress.
    Ningaraj NS
    Expert Opin Drug Deliv; 2006 Jul; 3(4):499-509. PubMed ID: 16822225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent advances in head and neck cancer therapy: the role of new cytotoxic and molecular-targeted agents.
    Caponigro F; Milano A; Basile M; Ionna F; Iaffaioli RV
    Curr Opin Oncol; 2006 May; 18(3):247-52. PubMed ID: 16552236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Editorial: Cytostatic treatment of brain tumors. Recent aspects].
    Hagen S
    Tidsskr Nor Laegeforen; 1973 Jun; 93(16):1257-8. PubMed ID: 4752600
    [No Abstract]   [Full Text] [Related]  

  • 17. Developing targeted therapies for lung cancer.
    Gandara DR
    Clin Adv Hematol Oncol; 2003 Nov; 1(11):648-9, 690. PubMed ID: 16258461
    [No Abstract]   [Full Text] [Related]  

  • 18. Experiences in vitro with cytostatic treatment.
    Gazsó L
    Minerva Neurochir; 1969; 13(3):257-9. PubMed ID: 5382576
    [No Abstract]   [Full Text] [Related]  

  • 19. Selective cytostatic and cytotoxic anticancer effects of bisfunctional agents: A strategy for the design of DNA binding agents.
    Spychała J
    Cancer Lett; 2009 Aug; 281(2):203-12. PubMed ID: 19303699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cytostatic therapy of malignant brain tumors].
    Schreml W
    Aktuelle Probl Chir Orthop; 1981; 18():58-66. PubMed ID: 6165253
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.